Neuraxis (NRXS)CEO bought ~$1.3K

~$1.3K

Approx. value · 268 sh @ $4.84

228K

Holds after · shares reported

Traded

Oct 8, 2026

Filed

Oct 8, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jul 24, 2026Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“of Certain Officers (e) Compensatory Arrangements of Certain Officers Stock Option Exchange As previously disclosed, on June 10, 2026, the stockholders of Neuraxis, Inc. (the “ Company ”) approved the cancellation of 1,319,394 outstanding stock options previously granted under the Innovative Health Solutions, Inc. 2017 Stock Compensation Plan, as amended, and the issuance of an equivalent amount of restricted stock…”
2. Oct 8, 2026 · this disclosureInsiderCEO purchased ~$1.3K of NRXS shares in the open market

What came next

1. Oct 8, 2026Insider · 2 peopleInsiders: 2 purchases (~$11K)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Neuraxis

For Neuraxis, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NRXS page.

Other recent filings by Brian Allen Carrico, Chief Executive Officer

• SEC Form 4 at Neuraxis (NRXS)Apr 3, 2026

The full history of Brian Allen Carrico, Chief Executive Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Neuraxis

• SEC Form 4Oct 8, 2026
• SEC Form 4Oct 8, 2026
• SEC Form 4Apr 3, 2026
• SEC Form 4Apr 3, 2026
• SEC Form 4Apr 3, 2026
• SEC Form 4Feb 13, 2026

Everything OQRO holds on this company is on its NRXS page.